Currently Browsing

Our Products

Niacin Extended-Release Tablets USP 750 mg – 90/Bottle

Overview

Reference Brand:
Niaspan®
Therapeutic Class:
Dyslipidemics

Specifications

GCN:
42332
Strength:
750 mg
Size:
90
NDC #:
59651001990
TE Code:
AB

Order Information

Case Qty (min order qty):
24
Case Weight (lbs):
7.48

Attributes

Physical Form:
Tablets
Shape:
Tablets
Color:
White to off-white
Imprint:
"T"/"66"
Prescribing Info
Product News

June 24, 2026 | Aurobindo Receives FDA Approval for Icosapent Ethyl Capsules, 1 gram ... Read more

Product News

June 09, 2026 | Aurobindo Receives FDA Approval for Cephalexin For Oral Suspension USP, 125 mg/5 mL and 250 mg/5 mL ... Read more

Product News

June 03, 2026 | Aurobindo Receives FDA Approval for Tofacitinib Tablets, 5 mg and 10 mg ... Read more